Hetero Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CABAZITAXEL, with a corresponding US DMF Number 28159.
Remarkably, this DMF maintains an Active status since its submission on April 21, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 15, 2014, and payment made on April 16, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II